miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway

Tianliang Zheng(First Affiliated Hospital of Zhengzhou University), Song Zhao(First Affiliated Hospital of Zhengzhou University)
Cancer Cell International
September 30, 2019
Cited by 38


Related Papers